Véronique Lecault
Founder at ABCELLERA BIOLOGICS INC.
Net worth: 43 M $ as of 31/03/2024
Profile
Dr. Véronique Lecault is a Vice President at Lineage Biosciences, Inc. and a Chief Operating Officer & Director at AbCellera Biologics, Inc. She is on the Board of Directors at Trianni, Inc., Channel Biologics Pty Ltd. and AbCellera Biologics, Inc. She received her undergraduate degree from the University of Ottawa and a doctorate degree from the University of British Columbia.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 14/01/2024 | 9,530,340 ( 3.26% ) | 43 M $ | 31/03/2024 |
Véronique Lecault active positions
| Companies | Position | Start |
|---|---|---|
| ABCELLERA BIOLOGICS INC. | Founder | 08/11/2012 |
Lineage Biosciences, Inc.
 Lineage Biosciences, Inc. Hospital/Nursing ManagementHealth Services Lineage Biosciences, Inc. engages in biotechnology services. The company was founded on May 30, 2014 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | 01/01/2018 |
| AbCellera Australia Pty Ltd. | Director/Board Member | 01/09/2019 |
Trianni, Inc.
 Trianni, Inc. BiotechnologyHealth Technology TRIANNI, Inc. operates as a biotech company. It specializes in antibody discovery technology using transgenic mice. Its Trianni Mouse platform enables the generation of fully-human monoclonal antibodies. The company was founded in 2010 and is headquartered in San Francisco, CA. | Director/Board Member | 01/11/2020 |
Training of Véronique Lecault
| University of British Columbia | Doctorate Degree |
| University of Ottawa | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ABCELLERA BIOLOGICS INC. | Health Technology |
| Private companies | 3 |
|---|---|
Trianni, Inc.
Trianni, Inc. BiotechnologyHealth Technology TRIANNI, Inc. operates as a biotech company. It specializes in antibody discovery technology using transgenic mice. Its Trianni Mouse platform enables the generation of fully-human monoclonal antibodies. The company was founded in 2010 and is headquartered in San Francisco, CA. | Health Technology |
Lineage Biosciences, Inc.
Lineage Biosciences, Inc. Hospital/Nursing ManagementHealth Services Lineage Biosciences, Inc. engages in biotechnology services. The company was founded on May 30, 2014 and is headquartered in Vancouver, Canada. | Health Services |
| AbCellera Australia Pty Ltd. |
- Stock Market
- Insiders
- Véronique Lecault
